Friday, June 05, 2009 3:17:15 PM
Re: Confusion and MNTA share price
I would see it as very unlikely that the generic Lovenox approval path confusion is having a significant effect on the PPS.
I would assume that any serious institutional money gets opinions from somebody who is well versed in this (and unrelated to the trash that gets published by the sell-side).
And I am dead certain that the average Joe investor has no clue what the discussion is even about. As a matter of fact, they would have no clue about any and all of 505B2, ANDA, biologic, low molecular weight herapins and small molecule drugs (except that the last one is semi descriptive).
If you don't believe me, just drop in a Y! MB for HEB
I would see it as very unlikely that the generic Lovenox approval path confusion is having a significant effect on the PPS.
I would assume that any serious institutional money gets opinions from somebody who is well versed in this (and unrelated to the trash that gets published by the sell-side).
And I am dead certain that the average Joe investor has no clue what the discussion is even about. As a matter of fact, they would have no clue about any and all of 505B2, ANDA, biologic, low molecular weight herapins and small molecule drugs (except that the last one is semi descriptive).
If you don't believe me, just drop in a Y! MB for HEB
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
